District Court in New Jersey, contends Lilly's ads are "deliberately simple and deliberately false" because they tout "outdated clinical trials that compare the highest doses of the Lilly medicines to lower doses of Novo Nordisks medicines." Novo said the ads are deceptive because they present results as "proof of broad, product-level superiority while burying or omitting critical clinical context." John Kuckelman, Novo's senior vice president and group general counsel, said Lilly's ads have misled consumers
This often resembles telogen effluvium, a temporary shedding pattern that can follow rapid weight loss, illness, surgery, childbirth, crash dieting or nutritional stress
This disconnect between tape measure results and scale readings is not a sign of failureit reflects how your body reshapes itself during GLP-1 therapy
For those managing diabetes or seeking to lose weight, semaglutide can be transformative, significantly improving health
Encapsulation efficiency refers to the percentage of active ingredient successfully entrapped within liposomes relative to the total amount used in formulation
Influence of microneedle shape on the transport of a fluorescent dye into human skin in vivo
